A clinical trial testing the effects of a Lyme disease vaccine proves to be successful so far in protecting the body from the infection.
A large drug trial studying the effects of Gammagard in stabilizing Alzheimer's disease proved to be ineffective.
The Food and Drug Administration stopped the drug trial of Sensipar after the death of a 14 year-old patient.